At the international trade fair MEDICA in Düsseldorf, scientists from Greifswald will introduce the first cold plasma-jet with the aim to improve wound healing. Together with its spin-off neoplas tools GmbH the Leibniz Institute of Plasma Science and Technology e.V. (INP Greifswald) will belong from November 12-15 to approximately 4600 exhibitors at the world’s largest medical trade fair. Their joint innovation: the plasma jet kINPen® MED to treat chronic wounds and pathogen-induced skin diseases. Certification as a medical device was received in collaboration with the University Medicine Greifswald and the Charité – Universitätsmedizin Berlin.
Based on many years of basic research, scientists of the Leibniz Institute in Greifswald verified that physical cold plasmas inactivate pathogens but also multi-resistant bacteria like MRSA Wound healing is stimulated by the anti-bacterial and proliferation-enhancing effects of physical plasma. Furthermore, clinical trials showed successful treatment of chronic ulcera (open leg ulcer, lower leg sore) with plasma applications. For about 4 million people in Germany suffering from chronic wounds plasma therapy could be an effective alternative to established therapies in wound treatment.
“In the last few years Greifswald became a leading international center of plasma medicine. Our research results served as basis for a successful product development and launch of the kINPen® MED by neoplas tools GmbH”, says the director of the INP Prof. Dr. Klaus-Dieter Weltmann. Just a few days ago neoplas tools GmbH was awarded with the Ludwig-Bölkow technology prize of the federal state of Mecklenburg-Vorpommern to honor the successful transfer of research and development results into commercialization.
Since the start of 2014, the plasma-jet is successfully employed in several clinics and dermatological practices. “We will use the trade fair to present the first therapeutic success and potential of plasma medicine to an international specialists”, explains Renate Schönebeck, General Manager of neoplas tools GmbH, the enterprise in Greifswald manufacturing and distributing the plasma jet.
For the scientists at the INP which are working in the field of application of physical plasmas in medicine is not yet exhausted. “Recent research results suggest that physical plasmas could be used to inactivate cancer cells”, Prof. Weltmann points out.
INP Greifswald and neoplas tools GmbH present their results of plasmamedical research as well as the plasma jet kINPen® MED in hall 15, booth G40. At the shared booth of the Fördergesellschaft WTSH (Wirtschaftsförderung und Technologietransfer Schleswig-Holstein – Promotion of Economic Development and Technology Transfer in Schleswig-Holstein) innovative medical devices of northern federal states are presented.
Please contact us for press enquiries or if you would like to have further information about INP Greifswald as well as the kINPen® MED and neoplas tools GmbH:
Strategic marketing & research transfer
phone: +49 159 – 0401 0814